Lupin gets FDA approval for treatment of skin infections
BALTIMORE — Lupin announced that it has received final approval for its Nystatin and Triamcinolone Acetonide Cream USP, 100,000 units/gram and 1mg/gram, from the United States Food and Drug Administration to market a generic version of Delcor Asset Corporation’s (Delcor) Mycolog-II Cream. Lupin’s Nystatin and Triamcinolone Acetonide Cream USP, 100,000 units/gram and 1mg/gram, is the generic
